| A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer KP Ng, AM Hillmer, CTH Chuah, WC Juan, TK Ko, ASM Teo, ... Nature medicine 18 (4), 521-528, 2012 | 666 | 2012 |
| MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes M Inomata, H Tagawa, YM Guo, Y Kameoka, N Takahashi, K Sawada Blood, The Journal of the American Society of Hematology 113 (2), 396-402, 2009 | 325 | 2009 |
| Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer–cell lymphoma/leukemia Y Yamanaka, H Tagawa, N Takahashi, A Watanabe, YM Guo, K Iwamoto, ... Blood, The Journal of the American Society of Hematology 114 (15), 3265-3275, 2009 | 275 | 2009 |
| Lineage involvement of stem cells bearing the philadelphia chromosome in chronic myeloid leukemia in the chronic phase as shown by a combination of fluorescence-activated cell … N Takahashi, I Miura, K Saitoh, AB Miura Blood, The Journal of the American Society of Hematology 92 (12), 4758-4763, 1998 | 230 | 1998 |
| A clinical analysis of 52 adult patients with hemophagocytic syndrome: the prognostic significance of the underlying diseases N Takahashi, A Chubachi, M Kume, Y Hatano, A Komatsuda, Y Kawabata, ... International journal of hematology 74, 209-213, 2001 | 215 | 2001 |
| The role of microRNA-150 as a tumor suppressor in malignant lymphoma A Watanabe, H Tagawa, J Yamashita, K Teshima, M Nara, K Iwamoto, ... Leukemia 25 (8), 1324-1334, 2011 | 206 | 2011 |
| Multicenter phase II study of bendamustine plus rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma K Ohmachi, N Niitsu, T Uchida, SJ Kim, K Ando, N Takahashi, ... Journal of clinical oncology 31 (17), 2103-2109, 2013 | 205 | 2013 |
| Discontinuation of imatinib in Japanese patients with chronic myeloid leukemia N Takahashi, T Kyo, Y Maeda, T Sugihara, K Usuki, T Kawaguchi, N Usui, ... Blood 118 (21), 3759, 2011 | 201 | 2011 |
| Influence of CYP3A5 and drug transporter polymorphisms on imatinib trough concentration and clinical response among patients with chronic phase chronic myeloid leukemia N Takahashi, M Miura, SA Scott, H Kagaya, Y Kameoka, H Tagawa, ... Journal of human genetics 55 (11), 731-737, 2010 | 187 | 2010 |
| Treatment-free remission after second-line nilotinib treatment in patients with chronic myeloid leukemia in chronic phase: results from a single-group, phase 2, open-label study FX Mahon, C Boquimpani, DW Kim, N Benyamini, NCD Clementino, ... Annals of internal medicine 168 (7), 461-470, 2018 | 149 | 2018 |
| A clinicopathological study of 20 patients with T/natural killer (NK)-cell lymphoma-associated hemophagocytic syndrome with special reference to nasal and nasal-type NK/T-cell … N Takahashi, I Miura, A Chubachi, AB Miura, S Nakamura International journal of hematology 74, 303-308, 2001 | 138 | 2001 |
| Correlation between imatinib pharmacokinetics and clinical response in Japanese patients with chronic‐phase chronic myeloid leukemia N Takahashi, H Wakita, M Miura, SA Scott, K Nishii, M Masuko, M Sakai, ... Clinical Pharmacology & Therapeutics 88 (6), 809-813, 2010 | 112 | 2010 |
| Fluorescence in situ hybridization of progenitor cells obtained by fluorescence-activated cell sorting for the detection of cells affected by chromosome abnormality trisomy 8 … K Saitoh, I Miura, N Takahashi, AB Miura Blood, The Journal of the American Society of Hematology 92 (8), 2886-2892, 1998 | 105 | 1998 |
| Evidence for immunologic immaturity of cord blood T cells. Cord blood T cells are susceptible to tolerance induction to in vitro stimulation with a superantigen. N Takahashi, K Imanishi, H Nishida, T Uchiyama Journal of immunology (Baltimore, Md.: 1950) 155 (11), 5213-5219, 1995 | 100 | 1995 |
| Deeper molecular response is a predictive factor for treatment-free remission after imatinib discontinuation in patients with chronic phase chronic myeloid leukemia: the JALSG … N Takahashi, T Tauchi, K Kitamura, K Miyamura, Y Saburi, Y Hatta, ... International journal of hematology 107, 185-193, 2018 | 92 | 2018 |
| Enucleation of human erythroblasts involves non-muscle myosin IIB K Ubukawa, YM Guo, M Takahashi, M Hirokawa, Y Michishita, M Nara, ... Blood, The Journal of the American Society of Hematology 119 (4), 1036-1044, 2012 | 88 | 2012 |
| Treatment-free remission after two-year consolidation therapy with nilotinib in patients with chronic myeloid leukemia: STAT2 trial in Japan N Takahashi, K Nishiwaki, C Nakaseko, N Aotsuka, K Sano, C Ohwada, ... Haematologica 103 (11), 1835, 2018 | 87 | 2018 |
| Monocyte-derived dendritic cells perform hemophagocytosis to fine-tune excessive immune responses H Ohyagi, N Onai, T Sato, S Yotsumoto, J Liu, H Akiba, H Yagita, ... Immunity 39 (3), 584-598, 2013 | 84 | 2013 |
| TRPM8 on mucosal sensory nerves regulates colitogenic responses by innate immune cells via CGRP PR de Jong, N Takahashi, M Peiris, S Bertin, J Lee, MG Gareau, ... Mucosal immunology 8 (3), 491-504, 2015 | 79 | 2015 |
| Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells A Tanaka, H Nishikawa, S Noguchi, D Sugiyama, H Morikawa, ... Journal of Experimental Medicine 217 (2), 2020 | 72 | 2020 |
